A pair of twins born after maternal exposure to leflunomide

Journal of Perinatology

Volumn 28, Issue 12, 2008, Pages 841-842

  Heine, K ^a   Poets, C F ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CAFFEINE; COLESTYRAMINE; INDOMETACIN; LEFLUNOMIDE;

ADULT; APNEA; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CESAREAN SECTION; CHILD DEVELOPMENT; DRUG BLOOD LEVEL; ECHOCARDIOGRAPHY; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS DISTRESS; FOLLOW UP; GESTATIONAL AGE; HEMORRHAGIC COLITIS; HUMAN; INTRAUTERINE GROWTH RETARDATION; JUVENILE RHEUMATOID ARTHRITIS; MONOZYGOTIC TWINS; NEWBORN ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PLACENTA INSUFFICIENCY; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; SMALL FOR DATE INFANT; TWINS;

ADULT; ANTIRHEUMATIC AGENTS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; ISOXAZOLES; PRE-ECLAMPSIA; PREGNANCY; TWINS, MONOZYGOTIC;

EID: 57049103536     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.118     Document Type: Article

References (6)

1. Brent RL. Teratogen update: Reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: Counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 2001; 63(2): 106-112.
2. Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus 2004; 13(9): 746-750.
3. De Santis M, Straface G, Cavaliere A, Carducci B, Caruso A. Paternal and maternal exposure to leflunomide: Pregnancy and neonatal outcome. Ann Rheum Dis 2005; 64(7): 1096-1097.
4. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: A survey of practice patterns and pregnancy outcomes. J Rheumatol 2003; 30(2): 241-246.
5. Lyons Jones K, Johnson DL, Chambers CD. Monitoring leflunomide (Arava) as a new potential teratogen. Teratology 2002; 65(5): 200-202.
6. Garne E. Atrial and ventricular septal defects - epidemiology and spontaneous closure. J Matern Fetal Neonatal Med 2006; 19 5): 271-276.